🔒 ★ National Drug Control Strategy (2026): A Comprehensive Approach to Combat Drug Addiction
The strategy addresses the fentanyl crisis as a national emergency.
High impact 390 min
Drug profile · INN
fentanyl
ABSTRAL
fentanyl (ABSTRAL) is a mu opioid receptor agonist. Associated with Apotex Pty Ltd. Route of administration: buccal. Current US regulatory status: approved.
FDA: approved EMA: approved TGA: approved Nervous system (N02) N02AB03
US status approved
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — fentanyl
- US status
- approved
- Class
- Nervous system (N02)
- Route
- BUCCAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
fentanyl (ABSTRAL) is a mu opioid receptor agonist. Associated with Apotex Pty Ltd. Route of administration: buccal. Current US regulatory status: approved.
Key facts
INN fentanyl
Brand ABSTRAL
Mechanism Mu opioid receptor agonist
Target Mu-type opioid receptor
Therapeutic class Nervous system (N02)
Route BUCCAL
Formulation SPRAY
ATC code N02AB03
Originator Apotex Pty Ltd
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related research
🔒 ★ Frequently asked questions
What is fentanyl?
fentanyl (ABSTRAL) is a mu opioid receptor agonist. Associated with Apotex Pty Ltd. Route of administration: buccal. Current US regulatory status: approved.
What is the brand name for fentanyl?
ABSTRAL is a marketed brand name for fentanyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fentanyl?
fentanyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.